Regular physical exercise training assists in preventing type 2 diabetes development: Focus on its antioxidant and anti-inflammatory properties

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Teixeira Lemos, Edite ^a   Nunes, Sara ^a   Teixeira, Frederico ^a   Reis, Flávio ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; EZETIMIBE; FATTY ACID; FIBRIC ACID DERIVATIVE; GAMMA INTERFERON; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; SULFONYLUREA DERIVATIVE; THIAZIDE DIURETIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BLOOD PRESSURE; BODY FAT DISTRIBUTION; CARDIOVASCULAR RISK; DYSLIPIDEMIA; EXERCISE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIMARY PREVENTION; PROTEIN BLOOD LEVEL; REVIEW; ZUCKER DIABETIC FATTY RAT; ANIMAL; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISEASE COURSE; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PREVENTIVE HEALTH SERVICE; RAT; RISK FACTOR; RISK REDUCTION;

ANIMALS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; EXERCISE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; OBESITY; OXIDATIVE STRESS; PREVENTIVE HEALTH SERVICES; RATS; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 79251551381     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-12     Document Type: Review

References (111)

1. International Diabetes Federation Diabetes: a global threat. Diabetes Atlas 2008, 1-15. Brussels, 3, International Diabetes Federation., http://www.eatlas.idf.org/index1397.html
2. Gaede PH, Jepsen PV, Larsen JN, Jensen GV, Parving HH, Pedersen OB. The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes. Ugeskr Laeger 2003, 165(26):2658-2661.
3. Hu FB. Sedentary lifestyle and risk of obesity and type 2 diabetes. Lipids 2003, 38(2):103-108. 10.1007/s11745-003-1038-4, 12733740.
4. Carvalhal MM, Padez MC, Moreira PA, Rosado VM. Overweight and obesity related to activities in Portuguese children, 7-9 years. Eur J Public Health 2007, 17(1):42-46. 10.1093/eurpub/ckl093, 16793838.
5. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, Shuai Y, Zhang B, Zhang J, Thompson T, Gerzoff RB, Roglic G, Hu Y, Bennett PH. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008, 371(9626):1783-1789. 10.1016/S0140-6736(08)60766-7, 18502303.
6. Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J, . Finnish Diabetes Prevention Study Group Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006, 368(9548):1673-1679. Finnish Diabetes Prevention Study Group.
7. Das SK, Elbein SC. The genetic basis of type 2 diabetes. Cellscience 2006, 2:100-131. 1526773, 16892160.
8. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005, 365:1333-1346. 10.1016/S0140-6736(05)61032-X, 15823385.
9. Eriksson J, Lindström J, Tuomilehto J. Potential for the prevention of type 2 diabetes. Br Med Bull 2001, 60:183-199. 10.1093/bmb/60.1.183, 11809626.
10. Zinman B. Type 2 diabetes mellitus: magnitude of the problem and failure to achieve glycaemic control. Endocrinol Metab Clin North Am 2006, 35:3-5. 10.1016/S0889-8529(07)70003-8, 17424673.
11. Praet SF, Manders RJ, Meex RC, Lieverse AG, Stehouwer CD, Kuipers H, Keizer HA, van Loon LJ. Glycaemic instability is an underestimated problem in Type II diabetes. Clin Sci (Lond) 2006, 111(2):119-126. 10.1042/CS20060041, 16613586.
12. Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat?. Diabetes 2005, 54:1-7. 10.2337/diabetes.54.1.1, 15616004.
13. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999, 48(1):1-9. 10.2337/diabetes.48.1.1, 9892215.
14. Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 2005, 7(7-8):1040-1052. 10.1089/ars.2005.7.1040, 15998259.
15. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction?. Diabetes 2003, 52:1-8. 10.2337/diabetes.52.1.1, 12502486.
16. Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, Kitagawa N, Tanaka T, Hori Y, Nakatani K, Yano Y, Adachi Y. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 2003, 88(10):4673-4676. 10.1210/jc.2003-030202, 14557439.
17. Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 2003, 52:581-587. 10.2337/diabetes.52.3.581, 12606496.
18. Talior I, Yarkoni M, Bashan N, Eldar-Finkelman H. Increased glucose uptake promotes oxidative stress and PKC-delta activation in adipocytes of obese, insulin-resistant mice. Am J Physiol Endocrinol Metab 2003, 285(2):E295-E302.
19. Evans JL. Antioxidants: do they have a role in the treatment of insulin resistance?. Indian J Med Res 2007, 125(3):355-372.
20. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002, 23(5):599-622. 10.1210/er.2001-0039, 12372842.
21. Yamamoto Y, Gaynor RB. Role of the NF-kappaB pathway in the pathogenesis of human disease states. Curr Mol Med 2001, 1(3):287-296. 10.2174/1566524013363816, 11899077.
22. Cardozo AK, Heimberg H, Heremens Y, Leeman R, Kutlu B, Kruhøffer M, Ørntoft T, Eizirik DL. A comprehensive analysis of cytokine-induced and nuclear factor-kB dependent genes in primary rat pancreatic β-cells. J Biol Chem 2001, 276:48879-48886. 10.1074/jbc.M108658200, 11687580.
23. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003, 112:1785-1788. 297006, 14679172.
24. Furler SM, Gan SK, Poynten AM, Chisholm DJ, Campbell LV, Kriketos AD. Relationship of adiponectin with insulin sensitivity in humans, independent of lipid availability. Obesity (Silver Spring) 2006, 14:228-234. 10.1038/oby.2006.29, 16571847.
25. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006, 116:1784-1792. 10.1172/JCI29126, 1483172, 16823476.
26. Cai W, Zhu L, Chen X, Uribarri J, Peppa M. Association of advanced glycoxidation end products and inflammation markers with thrombosis of arteriovenous grafts in hemodialysis patients. Am J Nephrol 2006, 26(2):181-185. 10.1159/000093122, 16675897.
27. Yano Y, Gabazza EC, Kitagawa N, Bruno NE, Matsumoto K, Nakatani K, Araki R, Katsuki A, Adachi Y, Sumida Y. Tumor necrosis factor-alpha is associated with increased protein C activation in nonobese type 2 diabetic patients. Diabetes Care 2004, 27(3):844-845. 10.2337/diacare.27.3.844, 14988320.
28. Maedler K, Spinas GA, Dyntar D, Moritz W, Kaiser N, Donath MY. Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes 2001, 50:69-76. 10.2337/diabetes.50.1.69, 11147797.
29. Cnop M, Hannaert JC, Grupping AY, Pipeleers DG. Low density lipoprotein can cause death of islet beta-cells by its cellular uptake and oxidative modification. Endocrinology 2002, 143(9):3449-3453. 10.1210/en.2002-220273, 12193557.
30. El-Assaad W, Buteau J, Peyot ML, Nolan C, Roduit R, Hardy S, Joly E, Dbaibo G, Rosenberg L, Prentki M. Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology 2003, 144:4154-4163. 10.1210/en.2003-0410, 12933690.
31. Poitout V, Robertson RP. Minireview: secondary beta-cell failure in type 2 diabetes: a convergence of glucotoxicity and lipotoxicity. Endocrinology 2002, 143:339-342. 10.1210/en.143.2.339, 11796484.
32. de Lemos ET, Reis F, Baptista S, Garrido AP, Pinto R, Sepodes B, Vala H, Rocha-Pereira P, Silva AS, Teixeira F. Efeitos do exercício físico aeróbio no perfil metabólico e oxidativo de ratos diabéticos tipo 2. Bull SPHM 2007, 22(1):16-28.
33. de Lemos ET, Reis F, Baptista S, Pinto R, Sepodes B, Vala H, Rocha-Pereira B, Silva AS, Teixeira F. Exercise training is associated with improved levels of C-reactive protein and adiponectin in ZDF (type 2) diabetic rats. Med Sci Monit 2007, 13(8):BR168-174.
34. Teixeira de Lemos E, Reis F, Baptista S, Pinto R, Sepodes B, Vala H, Rocha-Pereira, da Silva GC, Teixeira N, Silva AS, Carvalho L, Teixeira F, Das UN. Exercise training decreases proinflammatory profile in Zucker diabetic (type 2) fatty rats. Nutrition 2009, 25(3):330-339. 10.1016/j.nut.2008.08.014, 19062255.
35. Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycaemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 2001, 286(10):1218-1227.
36. Mourier A, Gautier JF, De Kerviler E, Bigard AX, Villette JM, Garnier JP, Duvallet A, Gurzennec CY, Cathelineau G. Mobilization of visceral adipose tissue related to the improvement in insulin sensitivity in response to physical training in NIDDM. Effects of branched-chain amino acid supplements. Diabetes Care 1997, 20(3):385-391. 10.2337/diacare.20.3.385, 9051392.
37. Hansen AK, Fischer CP, Plomgaard P, Andersen JL, Saltin B, Pedersen BK. Skeletal muscle adaptation: training twice every second day vs. training once daily. J Appl Physiol 2005, 98(1):93-99. 10.1152/japplphysiol.00163.2004, 15361516.
38. Eaton MD, Hodgson DR, Evans DL, Rose RJ. Effects of low- and moderate-intensity training on metabolic responses to exercise in thoroughbreds. Equine Vet J Suppl 1999, 30:521-527.
39. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, . Finnish Diabetes Prevention Study Group Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344(18):1343-1350. 10.1056/NEJM200105033441801, 11333990, Finnish Diabetes Prevention Study Group.
40. Sigal RJ, Kenny GP, Boulé NG, Wells GA, Prud'homme D, Fortier M, Reid RD, Tulloch H, Coule D, Phillips P, Jennings A, Jaffey J. Effects of aerobic training, resistance training, or both on glycaemic control in type 2 diabetes: a randomized trial. Ann Intern Med 2007, 147(6):357-369.
41. Ross R, Janssen I, Dawson J, Kungl AM, Kuk JL, Wong SL, Nguyen-Duy TB, Lee S, Kilpatrick K, Hudson R. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res 2004, 12(5):789-798. 10.1038/oby.2004.95, 15166299.
42. Lee S, Kuk JL, Davidson LE, Hudson R, Kilpatrick K, Graham TE, Ross R. Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without Type 2 diabetes. J Appl Physiol 2005, 99(3):1220-1225. 10.1152/japplphysiol.00053.2005, 15860689.
43. Király MA, Bates HE, Kaniuk NA, Yue JT, Brumell JH, Matthews SG, Riddell MC, Vranic M. Swim training prevents hyperglycemia in ZDF rats: mechanisms involved in the partial maintenance of beta-cell function. Am J Physiol Endocrinol Metab 2008, 294(2):E271-E283.
44. Boulè NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 2001, 286:1218-1227.
45. Boulè NG, Kenny GP, Hadda E, Wells GA. Sigal RJ Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetologia 2003, 46:1071-1081.
46. Christ-Roberts CY, Pratipanawatr T, Pratipanawatr W, Berria R, Belfort R, Kashyap S, Mandarino LJ. Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects. Metabolism 2004, 53(9):1233-1242. 10.1016/j.metabol.2004.03.022, 15334390.
47. Wang Y, Simar D, Fiatarone Singh MA. Adaptations to exercise training within skeletal muscle in adults with type 2 diabetes or impaired glucose tolerance: a systematic review. Diabetes Metab Res Rev 2009, 25(1):13-40. 10.1002/dmrr.928, 19143033.
48. Sato Y, Nagasaki M, Nakai N, Fushimi T. Physical exercise improves glucose metabolism in lifestyle-related diseases. Exp Biol Med 2003, 228(10):1208-1212.
49. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C. Physical activity/exercise and type 2 diabetes. Diabetes Care 2004, 27(10):2518-2539. 10.2337/diacare.27.10.2518, 15451933.
50. McArdle F, Spiers S, Aldemir H, Vasilaki A, Beaver A, Iwanejko L, McArdle A, Jackson MJ. Preconditioning of skeletal muscle against contraction-induced damage: the role of adaptations to oxidants in mice. J Physiol 2004, 561:233-244. 10.1113/jphysiol.2004.069914, 1665333, 15331678.
51. Berg A, Frey I, Baumstark MW, Halle M, Keul J. Physical activity and lipoprotein lipid disorders. Sports Med 1994, 17(1):6-21. 10.2165/00007256-199417010-00002, 8153500.
52. Goldhammer E, Ben-Sira D, Zaid G, Biniamini Y, Maor I, Lanir A, Sagiv M. Paraoxonase activity following exercise-based cardiac rehabilitation program. J Cardiopulm Rehabil Prev 2007, 27(3):151-154.
53. Romani R, De Medio GE, di Tullio S, Lapalombella R, Pirisinu I, Margonato V, Veicsteinas A, Marini M, Rosi G. Modulation of paraoxonase 1 and 3 expression after moderate exercise training in the rat. J Lipid Res 2009, 50(10):2036-2045. 10.1194/jlr.M800493-JLR200, 2739748, 19091700.
54. Luquet S, Gaudel C, Holst D, Lopez-Soriano J, Jehi-Pietri C, Fredenrich A, Grimaldi PA. Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes. Biochim Biophys Acta 2005, 1740(2):313-317.
55. Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, Clark JM, Curtis JM, Espeland MA, Foreyt JP, Graves K, Haffner SM, Harrison B, Hill JO, Horton ES, Jakicic J, Jeffery RW, Johnson KC, Kahn S, Kelley DE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montgomery B, Nathan DM, Patricio J, Peters A, Redmon JB, Reeves RS, Ryan DH, Safford M, Van Dorsten B, Wadden TA, Wagenknecht L, Wesche-Thobaben J, Wing RR, Yanovski SZ. Look AHEAD Research Group Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 2007, 30:1374-1383. 10.2337/dc07-0048, 2665929, 17363746, Look AHEAD Research Group.
56. Krook A, Holm I, Pettersson S, Wallberg-Henriksson H. Reduction of risk factors following lifestyle modification programme in subjects with type 2 (non-insulin dependent) diabetes mellitus. Clin Physiol Funct Imaging 2003, 23:21-30. 10.1046/j.1475-097X.2003.00463.x, 12558610.
57. De Feyter HM, Praet SF, van den Broek NM, Kuipers H, Stehouwer CD, Nicolay K, Prompers JJ, van Loon LJ. Exercise training improves glycemic control in long-standing insulin-treated type 2 diabetic patients. Diabetes Care 2007, 30(10):2511-2513. 10.2337/dc07-0183, 17626892.
58. Sigal RJ, Kenny GP, Boulé NG, Wells GA, Prud'homme D, Fortier M, Reid RD, Tulloch H, Coyle D, Phillips P, Jennings A, Jaffey J. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann Intern Med 2007, 147(6):357-369.
59. Lira FS, Yamashita AS, Uchida MC, Zanchi NE, Gualano B, Martins E, Caperuto EC, Seelaender M. Low and moderate, rather than high intensity strength exercise induces benefit regarding plasma lipid profile. Diabetol Metab Syndr 2010, 2:31. 10.1186/1758-5996-2-31, 2888772, 20492685.
60. Winder WW, Hardie DG. Inactivation of acetyl-CoA carboxylase and activation of AMP activated protein kinase in muscle during exercise. Am J Physiol 1996, 270(2 Pt 1):E299-304.
61. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002, 13(2):84-89. 10.1016/S1043-2760(01)00524-0, 11854024.
62. Pold R, Jensen LS, Jessen N, Buhl ES, Schmitz O, Flyvbjerg A, Fujii N, Goodyear LJ, Gotfredsen CF, Brand CL, Lund S. Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes 2005, 54(4):928-934. 10.2337/diabetes.54.4.928, 15793229.
63. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002, 136(7):493-503.
64. Chrysohoou C, Pitsavos C, Panagiotakos DB, Kokkinos PF, Stefanadis C, Toutouzas P. The association between physical activity and the development of acute coronary syndromes in treated and untreated hypertensive subjects. J Clin Hypertens 2003, 5(2):115-120.
65. Brum PC, Da Silva GJ, Moreira ED, Ida F, Negrao CE, Krieger EM. Exercise training increases baroreceptor gain sensitivity in normal and hypertensive rats. Hypertension 2000, 36(6):1018-1022.
66. Zinman B, Ruderman N, Campaigne BN, Devlin JT, Schneider SH, . American Diabetes Association Physical activity/exercise and diabetes mellitus. Diabetes Care 2003, 26(Suppl 1):S73-77. American Diabetes Association.
67. Thomas DE, Elliott EJ, Naughton GA. Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev 2006, 3:CD002968.
68. Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B. ADVANCE Collaborative Group Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007, 370:829-840. 10.1016/S0140-6736(07)61303-8, 17765963, ADVANCE Collaborative Group.
69. Bloomer RJ, Goldfarb AH. Anaerobic exercise and oxidative stress: a review. Can J Appl Physiol 2004, 29(3):245-263.
70. Di Meo S, Venditti P. Mitochondria in exercise-induced oxidative stress. Biol Signals Recept 2001, 10(1-2):125-140. 10.1159/000046880, 11223645.
71. Cooper CE, Vollaard NB, Choueiri T, Wilson MT. Exercise, free radicals and oxidative stress. Biochem Soc Trans 2002, 30(2):280-285. 10.1042/BST0300280, 12023865.
72. Urso ML, Clarkson PM. Oxidative stress, exercise, and antioxidant supplementation. Toxicology 2003, 189(1-2):41-54. 10.1016/S0300-483X(03)00151-3, 12821281.
73. Sen CK. Oxidants and antioxidants in exercise. J Appl Physiol 1995, 79(3):675-686.
74. Radak Z, Sasvari M, Nyakas C, Taylor AW, Ohno H, Nakamoto H, Goto S. Regular training modulates the accumulation of reactive carbonyl derivatives in mitochondrial and cytosolic fractions of rat skeletal muscle. Arch Biochem Biophys 2000, 383(1):114-118. 10.1006/abbi.2000.2042, 11097183.
75. Atalay M, Laaksonen DE. Diabetes, oxidative stress and physical exercise. J Sports Sci Med 2002, 1:1-14.
76. Gielen S, Adams V, Mobius-Winkler S, Linke A, Erbs S, Yu J, Kempf W, Schubert A, Schuler G, Hambrecht R. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 2003, 42(5):861-868. 10.1016/S0735-1097(03)00848-9, 12957433.
77. Fukai T, Siegfried MR, Ushio-Fukai M, Cheng Y, Kojda G, Harrison DG. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest 2000, 105(11):1631-1639. 10.1172/JCI9551, 10841522.
78. Leeuwenburgh C, Heinecke JW. Oxidative stress and antioxidants in exercise. Curr Med Chem 2001, 8(7):829-838.
79. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?. Hypertension 2003, 41:1183-1190. 10.1161/01.HYP.0000069700.62727.C5, 12707287.
80. Manzato E. Uric acid: an old actor for a new role. Intern Emerg Med 2007, 2(1):1-2. 10.1007/s11739-007-0001-6, 2780605, 17551676.
81. Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids 2008, 27(6):608-619. 10.1080/15257770802138558, 2895915, 18600514.
82. Fukai T, Siegfried MR, Ushio-Fukai M, Cheng Y, Kojda G, Harrison DG. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest 2000, 105(11):1631-1639. 10.1172/JCI9551, 300857, 10841522.
83. Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 2005, 45(10):1563-1569. 10.1016/j.jacc.2004.12.077, 15893167.
84. Fallon KE, Fallon SK, Boston T. The acute phase response and exercise: court and field sports. Br J Sports Med 2001, 35(3):170-173. 10.1136/bjsm.35.3.170, 1724337, 11375875.
85. Das UN. Anti-inflammatory nature of exercise. Nutrition 2004, 20(3):323-326. 10.1016/j.nut.2003.11.017, 14990277.
86. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005, 98(4):1154-1162. 10.1152/japplphysiol.00164.2004, 15772055.
87. Starkie R, Ostrowski SR, Jauffred S, Febbraio M, Pedersen BK. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J 2003, 17:884-886.
88. Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 2008, 88:1379-1406. 10.1152/physrev.90100.2007, 18923185.
89. Fisman EZ, Tenenbaum A. The ubiquitous interleukin-6: a time for Reappraisal. Cardiovasc Diabetol 2010, 9:62. 10.1186/1475-2840-9-62, 2959009, 20937099.
90. Pedersen BK. IL-6 signalling in exercise and disease. Biochemical Society Transactions 2007, 35:1295-1297. 10.1042/BST0351295, 17956334.
91. Febbraio MA, Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 2002, 16(11):1335-1347. 10.1096/fj.01-0876rev, 12205025.
92. Matthys P, Mitera T, Heremans H, Van Damme J, Billiau A. Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D- physique anxiety in older adults: fitness and efficacy influences. Aging Ment Health 2002, 6(3):222-230. 10.1080/13607860220142459, 12217090.
93. Keller C, Keller P, Giralt M, Hidalgo J, Pedersen BK. Exercise normalises overexpression of TNF-alpha in knockout mice. Biochem Biophys Res Commun 2004, 321(1):179-182. 10.1016/j.bbrc.2004.06.129, 15358232.
94. Wilund KR. Is the anti-inflammatory effect of regular exercise responsible for reduced cardiovascular disease?. Clin Sci (Lond) 2007, 112(11):543-55. 10.1042/CS20060368, 17459004.
95. Simpson KA, Singh MA. Effects of exercise on adiponectin: a systematic review. Obesity (Silver Spring) 2008, 16(2):241-256. 10.1038/oby.2007.53, 18239630.
96. Yatagai T, Nishida Y, Nagasaka S, Nakamura T, Tokuyama K, Shindo M, Tanaka H, Ishibashi S. Relationship between exercise training-induced increase in insulin sensitivity and adiponectinemia in healthy men. Endocr J 2003, 50(2):233-238. 10.1507/endocrj.50.233, 12803245.
97. Kriketos AD, Gan SK, Poynten AM, Furler SM, Chisholm DJ, Campbell LV. Exercise increases adiponectin levels and insulin sensitivity in humans. Diabetes Care 2004, 27(2):629-630. 10.2337/diacare.27.2.629, 14747265.
98. Martin-Cordero L, Garcia JJ, Giraldo E, De la Fuente M, Manso R, Ortega E. Influence of exercise on the circulating levels and macrophage production of IL-1beta and IFN gamma affected by metabolic syndrome: an obese Zucker rat experimental animal model. Eur J Appl Physiol 2009, 107(5):535-543. 10.1007/s00421-009-1140-4, 19688220.
99. Martín-Cordero L, García JJ, Hinchado MD, Bote E, Manso R, Ortega E. Habitual physical exercise improves macrophage IL-6 and TNF-α deregulated release in the obese Zucker rat model of the metabolic syndrome. Neuroimmunomodulation 2011, 18(2):123-130.
100. Ravin KR, Kamari Y, Navni I, Grossman E, Sharabi Y. Adiponectin: Linking the metabolic syndrome to its cardiovascular consequences. Expert Rev Cardiovasc Ther 2005, 3:465-471. 10.1586/14779072.3.3.465, 15889974.
101. Hull RL, Westermark GT, Westermark P, Kahn SE. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab 2004, 89:3629-3643. 10.1210/jc.2004-0405, 15292279.
102. Andersson AK, Flodström M, Sandler S. Cytokine-induced inhibition of insulin release from mouse pancreatic β-cells deficient in inducible nitric oxide synthase. Biochem Biophys Res Commun 2001, 281(2):396-403. 10.1006/bbrc.2001.4361, 11181061.
103. Donath MY, Böni-Schnetzler M, Ellingsgaard H, Halban PA, Ehses JA. Cytokine production by islets in health and diabetes: cellular origin, regulation and function. Trends in Endocrinol Metab 2010, 21(5):261-267.
104. Minato K, Shiroya Y, Nakae Y, Kondo T. The effect of chronic exercise on the rat pancreas. Int J Pancreatol 2000, 27(2):151-156. 10.1385/IJGC:27:2:151, 10862514.
105. Shima K, Zhu M, Noma Y, Mizuno A, Murakami T, Sano T, Kuwajima M. Exercise training in Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus: effects on the B-cell mass, insulin content and fibrosis in the pancreas. Diabetes Res Clin Pract 1997, 35(1):11-19. 10.1016/S0168-8227(96)01357-5, 9113470.
106. Dela F, von Linstow ME, Mikines KJ, Galbo H. Physical training may enhance beta-cell function in type 2 diabetes. Am J Physiol Endocrinol Metab 2004, 287(5):E1024-1031. 10.1152/ajpendo.00056.2004, 15251867.
107. Marso SP, Kennedy KF, House JA, McGuire DK. The effect of intensive glucose control on all-cause and cardiovascular mortality, myocardial infarction and stroke in persons with type 2 diabetes mellitus: a systematic review and meta-analysis. Diab Vasc Dis Res 2010, 7(2):119-130. 10.1177/1479164109353367, 20382775.
108. Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, Erqou S, Sattar N. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009, 373(9677):1765-1772. 10.1016/S0140-6736(09)60697-8, 19465231.
109. Lahaye SD, Gratas-Delamarche A, Malardé L, Vincent S, Zguira MS, Morel SL, Delamarche P, Zouhal H, Carré F, Bekono FR. Intense exercise training induces adaptation in expression and responsiveness of cardiac b-adrenoceptors in diabetic rats. Cardiovasc Diabetol 2010, 9:72. 10.1186/1475-2840-9-72, 2992048, 21054861.
110. Leehey DJ, Moinuddin I, Bast JP, Qureshi S, Jelinek CS, Cooper C, Edwards LC, Smith BM, Collins EG. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study. Cardiovasc Diabetol 2009, 8:62. 10.1186/1475-2840-8-62, 2796994, 20003224.
111. Kasi{dotless}may O, Ergen N, Bilsel S, Kaçar O, Deyneli O, Gogas D, Akali{dotless}n S, Yeǧen B, Kurtel H. Diet-supported aerobic exercise reduces blood endothelin-1 and nitric oxide levels in individuals with impaired glucose tolerance. J Clin Lipidol 2010, 4(5):427-434.